CTT Pharmaceutical Holdings, Inc.
corporate_fare Company Profile
CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for CTTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 10/10, with 5 rated 8 or above. Recent SEC coverage for CTTH spans 10-Q, 8-K, S-1/A.
Recent high-impact activity:
- CTT Pharma Q3 2026: Cash Down to $12,625, Loss Widens to $127,064, Going Concern Stands
- Auditor Resigns at CTT Pharma Amid Going-Concern Warning
- CTT Pharma Q2 10-Q: Going Concern, $31 Cash, Two Material Weaknesses
- CTT Pharma Amends S-1 to Detail $1M ELOC Use, Reports Nicotine Strip Patent Approval
- CTT Pharma Amends S-1 to Register 6.25M Shares for Resale Under $10M Equity Line, Details Use of Proceeds
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 19,151 shares in CTTH as of the October 30, 2026 settlement, a 5.5% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 8.5% of CTTH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for CTTH, detected from its recent SEC filings · based on capital-structure filings through 2026-07-13.
Fifth Amendment to S-1 Filed · No New Material Terms
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →